Increasing Utilization of Biophotonics in Research and Medical Applications to Boost Biophotonics Market

Biophotonics means a combination of photonics and biology, with photonics being the science of generation, detection, and manipulation of photons. Biophotonics is majorly the application and development of optical techniques, especially in imaging and the study of cells, biological molecules, and tissues. The market for biophotonics has grown exponentially over the years due to its increasing applications within the field of medicine, research, agriculture, and environmental science. In addition, the increasing demand for quality healthcare globally has also emerged as a chief growth factor for the biophotonics market.

Transparency Market Research (TMR), a market research company, highlights the prime application areas of biophotonics within research and medicine, thus throwing light on the condition of the market in the coming years.

•  Diagnostics: Laser-induced fluorescence has emerged as an active research field within a number of nations. It is utilized for early diagnosis of cancer in the lungs and gastrointestinal tract. Normal tissue is differentiated from cancerous and precancerous sites on the basis of emitted color or spectrum of the light. Cancerous sites tend to emit less overall light at longer wavelengths. This difference in emission spectra is owing to the anatomical changes as well as the presence of numerous fluorescing biomolecules. Thus, physicians are able to identify the suspicious sites for carrying out biopsies.

•  Therapeutics: Photodynamic therapy is approved as a new cancer treatment modality for a number of early-stage cancers as well as for palliative care. This therapy takes place by the systematic administration of a non-toxic drug known as a photosensitizer. A laser-provided red light is directed upon the tumor tissue, which is then absorbed by the photosensitizer, resulting in toxic components that are short-lived. The clinical utilization of photodynamic therapy is presently available for lung, brain, GI tract, skin, and prostate cancers.

•  Biotechnology: Though modern biotechnology is all about the knowledge of molecular biology, the quantification and determination of mRNA and DNA are performed by optical methods in order to extract information, majorly via the utilization of fluorescent-labelled antibodies. This is seen in confocal fluorescence microscopy, flow cytometry, and GeneChips. There are still certain limitations in the standard optical techniques within biotechnology and molecular biology, however, these limitations can be overcome via the utilization of better wavelength selectivity on the detection and source sites.

Browse Press Release:http://www.transparencymarketresearch.com/pressrelease/biophotonics-market.htm

Thus, the utilization of photons in diagnostic, biotechnology, and therapeutic applications will rise exponentially in forthcoming years. A number of huge optoelectronic and optical companies are creating their own optics and bioengineering divisions. Hence, biotech companies that have in-house photonics or collaborate with other photonics market players are poised to grow immensely in the coming years. The major companies dominant in the biophotonics market are Becton Dickinson & Co., PerkinElmer, Inc., Hamamatsu Photonics K.K., Carl Zeiss A.G., Olympus Corporation, Affymetrix Inc., and Oxford Instruments Plc., among others.